Meetings:

Federal Register: December 13, 2010 (Volume 75, Number 238)

Notices

Page 77650

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

DOCID:fr13de10-68

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Institute of Allergy and Infectious Diseases; Notice of

Closed Meeting

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5

U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Allergy and Infectious

Diseases Special Emphasis Panel; Ancillary Studies in

Immunomodulation Clinical Trails.

Date: January 6, 2011.

Time: 12 p.m. to 4:30 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6700B Rockledge Drive,

Bethesda, MD 20817. (Telephone Conference Call)

Contact Person: Lakshmi Ramachandra, Ph.D., Scientific Review

Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, Room 2217, 6700-B Rockledge Drive, MSC-7616, Bethesda, MD 20892-7616, 301-496- 2550, Ramachandral@niaid.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855,

Allergy, Immunology, and Transplantation Research; 93.856,

Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

Dated: December 7, 2010.

Jennifer S. Spaeth,

Director, Office of Federal Advisory Committee Policy.

FR Doc. 2010-31181 Filed 12-10-10; 8:45 am

BILLING CODE 4140-01-P

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT